Screener
Maravai LifeSciences Holdings, Inc. MRVI Cygnus — Restructuring
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001823239-26-000024
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s cygnus — restructuring?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — restructuring of -$3K in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s cygnus — restructuring changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s cygnus — restructuring decreased by 122.2% year-over-year, from $13.5K to -$3K.
- What does cygnus — restructuring mean?
- Aggregates all costs associated with significant changes to the organizational structure or business model of the Biologics Safety Testing segment. This metric is used to isolate non-recurring expenses that do not reflect ongoing core operations. Investors use this to normalize earnings and evaluate the long-term impact of strategic pivots.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — restructuring.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude